The State of Texas Attorney General Takes Legal Action Against Tylenol Makers Regarding Autism Spectrum Claims

Legal Proceedings
Ken Paxton, a Trump ally seeking election to US Senate, claimed pharmaceutical manufacturers of hiding potential dangers of Tylenol

Texas Attorney General Ken Paxton is filing a lawsuit against the manufacturers of acetaminophen, claiming the firms hid potential risks that the drug created to children's cognitive development.

This legal action follows a month after Former President Trump advocated an unproven link between consuming acetaminophen - alternatively called acetaminophen - throughout gestation and autism spectrum disorder in children.

Paxton is suing J&J, which previously sold the drug, the only pain reliever suggested for pregnant women, and the current manufacturer, which currently produces it.

In a statement, he stated they "betrayed America by profiting off of pain and promoting medication without regard for the potential hazards."

The company says there is lacking scientific proof tying Tylenol to autism.

"These corporations deceived for years, deliberately risking millions to increase profits," the attorney general, a Republican, declared.

Kenvue said in a statement that it was "seriously troubled by the dissemination of inaccurate information on the reliability of paracetamol and the potential impact that could have on the health of women and children in America."

On its website, the company also said it had "continuously evaluated the relevant science and there is lacking reliable evidence that shows a established connection between consuming acetaminophen and autism spectrum disorder."

Organizations acting on behalf of doctors and health professionals agree.

The leading OB-GYN organization has said paracetamol - the key substance in Tylenol - is among limited choices for pregnant women to treat discomfort and fever, which can present significant medical dangers if left untreated.

"In over twenty years of studies on the utilization of acetaminophen in gestation, not a single reputable study has definitively established that the use of acetaminophen in any period of pregnancy leads to neurodevelopmental disorders in children," the association commented.

The lawsuit references latest statements from the former administration in claiming the medication is allegedly unsafe.

Last month, Trump caused concern from medical authorities when he advised women during pregnancy to "struggle intensely" not to take acetaminophen when sick.

The US Food and Drug Administration then issued a notice that medical professionals should think about restricting the usage of Tylenol, while also stating that "a proven link" between the medication and autism in children has not been proven.

Health Secretary Kennedy, who oversees the FDA, had promised in spring to undertake "extensive scientific investigation" that would establish the cause of autism spectrum disorder in a short period.

But experts warned that discovering a sole reason of autism spectrum disorder - thought by researchers to be the consequence of a intricate combination of inherited and external influences - would not be simple.

Autism spectrum disorder is a category of lifelong neurodivergence and condition that affects how individuals encounter and interact with the world, and is identified using doctors' observations.

In his court filing, the attorney general - who supports Trump who is seeking US Senate - asserts Kenvue and J&J "intentionally overlooked and sought to suppress the research" around paracetamol and autism spectrum disorder.

This legal action seeks to make the firms "eliminate any marketing or advertising" that states Tylenol is reliable for women during pregnancy.

This legal action parallels the grievances of a collection of guardians of children with autism and attention deficit hyperactivity disorder who took legal action against the makers of acetaminophen in 2022.

The court threw out the lawsuit, saying investigations from the family's specialists was lacking definitive proof.

Brian Curry
Brian Curry

A seasoned journalist with a passion for digital media and storytelling, bringing fresh perspectives to global events.